
2.50 Delayed Data As of 3:59pm ET | ![]() Today’s Change | 1.41 Today|||52-Week Range 3.55 | +34.41% Year-to-Date |
SECTOR Health Technology | INDUSTRY Pharmaceuticals: Major | MARKET CAP $171.2M |
Ovid Therapeutics, Inc. 1460 Broadway New York New York 10036 |
Jeremy Max Levin | Chairman, President & Chief Executive Officer |
Jason Tardio | Chief Operating Officer |
Jeffrey A. Rona | Chief Financial & Business Officer |
Claude Nicaise | Head-Research & Development |
Julia Tsai | Senior VP-Clinical Development & Medical Affairs |